🔧 Filters
Try: author name · keyword phrase · DOI
Original Article
Background: Dyslipidemia, characterized by abnormal blood lipid levels, is a major risk factor for cardiovascular disease, contributing to an estimated 4.2 million deaths and disabilities globally. Th
CholesterolDyslipidemiaHDLLDLLipid ProfileTriglycerides
Original Article
Background: Although statins remain the cornerstone of lipid-lowering therapy, LDL-C targets are often not achieved with statin monotherapy. This study evaluated the effectiveness and tolerability of
Dyslipidemialow-density lipoprotein cholesterolrosuvastatinezetimibecombination therapyatherosclerotic cardiovascular disease.
Original Article
Introduction: Pediatric metabolic screening is governed by a weight-centric dualism that prioritizes obesity while overlooking cardiometabolic risks in undernutrition. While obesity-related dyslipidem
Pediatric ObesityGrowth DisordersDyslipidemiasChild Health Services.
Review Article
Syndrome X, the clustering of insulin resistance, atherogenic dyslipidemia, central obesity, hypertension and impaired glucose regulation first described by Gerald Reaven in his 1988 Banting Lecture,
Syndrome Xmetabolic syndromeinsulin resistancegenetic architecturecandidate genesFTO
Original Article
Objective: To evaluate the association between early second-trimester serum lipid concentrations and the subsequent risk of developing gestational hypertension and preeclampsia. Design: A prospective
DyslipidemiaEndothelial dysfunctionGestational hypertensionLipid profilePregnancysingleton pregnancies